What does APOTHEEK BULTYNCK do?

APOTHEEK BULTYNCK is a pharmacy in Oostende. Private Limited, started on 9 May 2000, 1 establishment.

What is the address of APOTHEEK BULTYNCK?

The registered office of APOTHEEK BULTYNCK is located at Elisabethlaan 366, 8400 Oostende.

Is APOTHEEK BULTYNCK still active?

Yes. According to the CBE (29 October 2026) APOTHEEK BULTYNCK is active, legal situation “Normale toestand”, started on 9 May 2000.

Is APOTHEEK BULTYNCK registered on Peppol?

Yes, APOTHEEK BULTYNCK is registered on the Peppol network with ID 0208:0471846305.

What is the enterprise number of APOTHEEK BULTYNCK?

The enterprise number of APOTHEEK BULTYNCK is BE0471846305.

When was APOTHEEK BULTYNCK founded?

APOTHEEK BULTYNCK was founded on 9 May 2000.

Who are the directors of APOTHEEK BULTYNCK?

According to the 2025 annual accounts, the directors of APOTHEEK BULTYNCK are: Sodiap BV, Alexo BV, Camiflo BV.

Is APOTHEEK BULTYNCK a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 9 May 2000; 5 annual accounts filed, latest fiscal year 2025; 3 directors known from the annual account.

How much profit did APOTHEEK BULTYNCK make in 2025?

APOTHEEK BULTYNCK posted a profit after taxes of € 6,589 in financial year 2025.

What is the revenue of APOTHEEK BULTYNCK?

As a small company, APOTHEEK BULTYNCK is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 147,088.

How much does an employee at APOTHEEK BULTYNCK earn?

The average wage cost per full-time employee at APOTHEEK BULTYNCK was € 76,200 in 2025: staff costs of € 152,336 for 2 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK BULTYNCK have?

According to the 2025 annual accounts, APOTHEEK BULTYNCK has 2 full-time equivalents (FTE).

Does APOTHEEK BULTYNCK have a website?

Yes, APOTHEEK BULTYNCK has a website at apotheekbultynck.be.

APOTHEEK BULTYNCK (Private Limited) - Oostende

Dossier APOTHEEK BULTYNCK, printed on 29 October 2026 from databakkes.be/en/0471846305/apotheek-bultynck. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK BULTYNCK from Oostende, company number BE0471846305, closed financial year 2025 with a result of € 6,589 after tax. For that financial year APOTHEEK BULTYNCK recorded a gross margin of € 147,088 and equity of € 1.2 million. Compared with financial year 2024, the result moved from € 38,850 to € 6,589. The company is profitable. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 12, 2026.

What it is worth Growing

€ 1.2 million

▲ 1% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 6,589

▼ 83% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 4,036

▲ 12% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 861,149.

People and assets in 2025

Full-time equivalents

▼ 0.7 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 152,336

▼ 18% vs 2024

€ 76,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 5,871

▲ 222% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 187,881

▲ 22% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Wages and social charges

€ 15,570

▼ 32% vs 2024

Wages, holiday pay and social contributions still to pay. No outstanding taxes.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 303,740 Gross margin 2022: € 303,740 First fiscal year in the series	€ 255,449 Gross margin 2023: € 255,449 ▼ 16% vs 2022 (€ 303,740) Unfavourable step	€ 226,766 Gross margin 2024: € 226,766 ▼ 11% vs 2023 (€ 255,449) Unfavourable step	€ 147,088 Gross margin 2025: € 147,088 ▼ 35% vs 2024 (€ 226,766) Unfavourable step	▼ 35%
Profit after taxes	€ 116,394 Profit after taxes 2022: € 116,394 First fiscal year in the series	€ 63,467 Profit after taxes 2023: € 63,467 ▼ 45% vs 2022 (€ 116,394) Unfavourable step	€ 38,850 Profit after taxes 2024: € 38,850 ▼ 39% vs 2023 (€ 63,467) Unfavourable step	€ 6,589 Profit after taxes 2025: € 6,589 ▼ 83% vs 2024 (€ 38,850) Unfavourable step	▼ 83%
Equity	€ 1,087,997 Equity 2022: € 1,087,997 First fiscal year in the series	€ 1,151,464 Equity 2023: € 1,151,464 ▲ 6% vs 2022 (€ 1,087,997) Favourable step	€ 1,190,314 Equity 2024: € 1,190,314 ▲ 3% vs 2023 (€ 1,151,464) Favourable step	€ 1,196,902 Equity 2025: € 1,196,902 ▲ 1% vs 2024 (€ 1,190,314) Favourable step	▲ 1%
Total debts	€ 152,577 Total debts 2022: € 152,577 First fiscal year in the series	€ 222,483 Total debts 2023: € 222,483 ▲ 46% vs 2022 (€ 152,577) Unfavourable step	€ 176,398 Total debts 2024: € 176,398 ▼ 21% vs 2023 (€ 222,483) Favourable step	€ 203,451 Total debts 2025: € 203,451 ▲ 15% vs 2024 (€ 176,398) Unfavourable step	▲ 15%
Cash	€ 8,780 Cash 2022: € 8,780 First fiscal year in the series	€ 5,633 Cash 2023: € 5,633 ▼ 36% vs 2022 (€ 8,780) Unfavourable step	€ 3,602 Cash 2024: € 3,602 ▼ 36% vs 2023 (€ 5,633) Unfavourable step	€ 4,036 Cash 2025: € 4,036 ▲ 12% vs 2024 (€ 3,602) Favourable step	▲ 12%
Land & buildings	€ 116,733 Land & buildings 2022: € 116,733 First fiscal year in the series	€ 92,389 Land & buildings 2023: € 92,389 ▼ 21% vs 2022 (€ 116,733) Unchanged	€ 75,059 Land & buildings 2024: € 75,059 ▼ 19% vs 2023 (€ 92,389) Unchanged	€ 74,368 Land & buildings 2025: € 74,368 ▼ 1% vs 2024 (€ 75,059) Unchanged	▼ 1%
Retained profit	€ 752,244 Retained profit 2022: € 752,244 First fiscal year in the series	€ 815,711 Retained profit 2023: € 815,711 ▲ 8% vs 2022 (€ 752,244) Favourable step	€ 854,561 Retained profit 2024: € 854,561 ▲ 5% vs 2023 (€ 815,711) Favourable step	€ 861,149 Retained profit 2025: € 861,149 ▲ 1% vs 2024 (€ 854,561) Favourable step	▲ 1%
Balance sheet total	€ 1,240,575 Balance sheet total 2022: € 1,240,575 First fiscal year in the series	€ 1,373,947 Balance sheet total 2023: € 1,373,947 ▲ 11% vs 2022 (€ 1,240,575) Unchanged	€ 1,366,712 Balance sheet total 2024: € 1,366,712 ▼ 1% vs 2023 (€ 1,373,947) Unchanged	€ 1,400,353 Balance sheet total 2025: € 1,400,353 ▲ 2% vs 2024 (€ 1,366,712) Unchanged	▲ 2%
Employees (FTE)	1.7 Employees (FTE) 2022: 1.7 First fiscal year in the series	2.5 Employees (FTE) 2023: 2.5 ▲ 0.8 vs 2022 (1.7) Unchanged	2.7 Employees (FTE) 2024: 2.7 ▲ 0.2 vs 2023 (2.5) Unchanged	2 Employees (FTE) 2025: 2 ▼ 0.7 vs 2024 (2.7) Unchanged	▼ 0.7

Key figures of APOTHEEK BULTYNCK, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK BULTYNCK?

What happened at APOTHEEK BULTYNCK in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 12, 2026 New annual accounts for financial year 2025: profit of € 6,589 (▼ 83% vs 2024). Source: NBB ↗
2022 Alexo BV became a director. NBB
2020 Sodiap BV became a director. NBB
2020 Camiflo BV became a director. NBB
Jun 20, 2000 New establishment in Oostende. KBO
May 9, 2000 Start of the company according to the CBE. KBO

In short

From € 116,394 profit in 2022 to € 6,589 profit in 2025.

Paid € 82,088 in corporate taxes since 2022.

Best year ever: 2022, with € 116,394 profit.

On average € 73,500 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

SODIAP 100%

The stake of SODIAP comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK BULTYNCK

Behind APOTHEEK BULTYNCK are Sodiap BV, Alexo BV and Camiflo BV. The shares are held by SODIAP (100%).

Directors

According to the 2025 annual accounts

Sodiap BV

Managing director · represented by Tom Goderis

Also active at: SDC, HC Pharma, APOTHEEK JENNE, Apotheek de Lisseweg, Apotheek Seurinck, APOTHEEK SCARPHOUT, C.E. FARMA, SANIFAR +24 more

since 2020

Alexo BV

Chairman of the board · represented by Olivier Delaere

Also active at: SDC, HC Pharma, SODIAP, APOTHEEK JENNE, PANNOC CHEMIE, Apotheek de Lisseweg, Apotheek Seurinck, APOTHEEK SCARPHOUT +34 more

since 2022

Camiflo BV

Managing director · represented by Frank Bultynck

Also active at: BOFRAST, YPSILON CONSTRUCT, Ypsilon Vastgoed

since 2020

Shareholders

SODIAP

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Elisabethlaan 366

8400 Oostende

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS apotheekbultynck.be

About

Technologies

AMPAdobe FontsAlpine.jsCookie ConsentNginxPlausibleVimeoYouTube EmbedreCAPTCHA

Hosting & Email

Email provider

Microsoft 365

Hosting

UPCLOUD, FI

Website info

HTTPS Ja

Indexable pages 106,233

Languages FR, NL

Features

Webshop Newsletter Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ IPv6

Details

Company number

0471.846.305

VAT number

BE 0471.846.305

Registered office

Elisabethlaan 366, 8400 Oostende

Names & denominations

APOTHEEK BULTYNCK

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

9 May 2000

Peppol

Active · Active since 6 Jun 2025

Contact

apotheekbultynck.be

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

Verhuur en lease van medisch en paramedisch materieel

Detailhandel in cosmetica en toiletartikelen

Detailhandel in medische en orthopedische artikelen, muv corrigerende brillen, lenzen en zonnebrillen

Verhuur van medisch en paramedisch materieel

Detailhandel in medische en orthopedische artikelen

Detailhandel in medische en orthopedische artikelen in gespecialiseerde winkels

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK BULTYNCK

Financials

What happened to APOTHEEK BULTYNCK?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Website

Technologies

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions